Home
NICE Guidance
Published Guidance
Everolimus for the second-line treatment of advanced renal cell carcinoma
Technology appraisal guidance [TA219]
Published date:
19 April 2011
Guidance
This guidance has been updated and replaced by
NICE technology appraisal guidance 432
.